Medical Disclaimer: This article is for educational and informational purposes only and does not constitute individual medical advice, diagnosis, or clinical treatment. Always consult your personal physician or qualified healthcare provider regarding medical conditions, prescription changes, or new health regimens.
Transparency Disclosure: Dibesity features independent, evidence-based medical research. Some articles may contain vetted affiliate links to metabolic wellness products; if you make a purchase, we may earn a modest commission at no extra cost to you.
Introduction
Skin conditions range from small, short-lived rashes to long-term diseases that affect sleep, work, confidence and daily life.
Doctors who treat them rely on guidelines, which are written recommendations that summarize the best available knowledge about diagnosis and treatment.
Some treatments are supported by strong and consistent evidence. Others are based mainly on expert opinion because high-quality studies have not yet been done.
This article reviews recent dermatology guidelines, consensus statements and reviews. It explains what these sources say about four skin-related topics: chronic hand eczema, cutaneous graft-versus-host disease, skin and hair changes during menopause, and tinea capitis, a fungal infection of the scalp. It also explains where the evidence is solid and where important questions remain open.
What Is Evidence-Based Dermatology?
Evidence-based medicine means using the best available research, combined with clinical experience and the needs of each patient, to make treatment decisions.
Research comes in different strengths. Randomized controlled trials, in which people are assigned to treatments by chance, are generally considered strong evidence.
Guidelines and expert consensus statements are also useful, but they often reflect the judgment of specialists when trial data are limited.
The sources used in this article are guidelines, consensus statements and narrative reviews. None of them is a randomized trial.
This matters because it means the recommendations described here are best understood as organized clinical guidance rather than proof from large, controlled experiments.
Why Does It Matter?
Skin disease is common, and it can be more than a cosmetic problem. Chronic hand eczema, for example, is described as causing long-lasting symptoms, limits on daily function, and a high psychosocial and economic burden [2].
Clear guidance helps doctors choose treatments that are appropriate, safe and proven to be useful when possible.
Guidelines also help reduce confusion. Dermatology has seen many new drugs in recent years, and a reader may hear about several options at once.
Understanding how a treatment fits into a stepwise plan can make a conversation with a doctor more productive.
What Does the Latest Research Show?
Cutaneous Graft-versus-Host Disease
Graft-versus-host disease (GVHD) can occur after a stem cell transplant, when donor immune cells attack the recipient’s body. The skin is one of the organs most often affected [1].
Mild skin involvement is commonly treated with topical corticosteroids, which are creams applied to the skin, along with supportive skin care [1].
Moderate to severe disease usually requires systemic corticosteroids, which act throughout the body.
However, the review notes that up to 60% of patients may develop steroid-refractory or steroid-resistant disease, meaning the steroids do not work well enough [1].
This has driven interest in other options, including targeted systemic agents such as ruxolitinib, belumosudil, axatilimab, ibrutinib and abatacept. Each targets a different immune pathway, and their use depends on established algorithms or specific clinical situations [1].
Some approaches are still emerging. Topical ruxolitinib, light-based therapies and extracorporeal photopheresis, a procedure that treats blood outside the body, may be used as add-on treatments for persistent or localized skin disease [1].
Mesenchymal stromal cells and regulatory T cells are described as promising but still experimental [1].
Chronic Hand Eczema
Chronic hand eczema is a long-lasting inflammatory rash. Diagnosis includes a detailed history, examination, and patch testing, which is considered the gold standard for finding relevant contact allergies [2].
Severity can be measured with clinician-rated tools and with patient questionnaires, such as the Quality of Life in Hand Eczema Questionnaire [2].
Treatment usually follows a stepwise plan. Topical corticosteroids remain first-line therapy. Phototherapy, alitretinoin and immunosuppressants are reserved for refractory cases [2].
Newer options described in the review include topical delgocitinib and the biologic dupilumab, particularly for atopic forms of hand eczema [2].
These newer approaches expand choices, but the review emphasizes that the evidence base is still developing.
Menopausal Skin and Hair Changes
Menopause affects the skin and hair as well as hormones. Changes can include a weaker skin barrier, thinning, laxity, pigment changes, hair loss or excess hair growth, acne, rosacea and vulvovaginal symptoms.
These changes are linked to falling estrogen levels and a relative excess of androgens, which are male-type hormones present in all sexes [3].
Dermatologists play a role in managing these concerns, often as part of a wider menopause care team [3].
The review discusses menopausal hormone therapy and its effects on the skin, including recent regulatory changes and evolving evidence on topical and systemic estrogen.
It also highlights areas where the evidence is limited [3]. Because the research is mixed, decisions about hormone therapy should be personalized.
Tinea Capitis in Children
Tinea capitis is a fungal infection of the scalp caused by dermatophytes, a group of fungi that also cause ringworm.
It mainly affects children and is common worldwide [5]. In Europe, the types of fungi causing infection have shifted, with more cases caused by Trichophyton tonsurans and Trichophyton violaceum, which spread easily between people [5].
A German consensus guideline recommends combining systemic and topical antifungal treatment, because topical treatment alone is generally not enough [5].
In children, the choice of oral medicine depends on the species found. Trichophyton infections are preferably treated with terbinafine, while Microsporum or Nannizzia infections are treated with itraconazole or griseofulvin.
These uses are described as off-label, meaning they are not the officially labeled use of the drug [5]. In adults, terbinafine is recommended as first-line therapy regardless of the species [5].
The guideline also addresses preventing spread. It recommends treating asymptomatic carriers, practicing hygiene and managing outbreaks in community settings [5].
How Do These Treatments Work?
Many of the newer skin treatments target the immune system. The immune system uses cells and chemical messengers to fight threats.
In some skin diseases, these messages become overactive and keep inflammation going. Targeted drugs try to block specific steps in this process, such as particular signaling pathways inside immune cells [1,2].
Cell-based approaches work differently. Regulatory T cells are immune cells that help calm excessive responses.
Researchers are studying whether they can be used therapeutically, but the review describes this work as early [1]. Antifungal drugs, by contrast, work directly against the fungus.
Terbinafine, itraconazole and griseofulvin each act on fungal cells in different ways, and the choice depends on the organism [5].
Biological plausibility is not the same as proof. A treatment can make sense on paper and still fail to help patients in real life. Readers should treat mechanisms as explanations for why a therapy might work, not as evidence that it does.
Who May Benefit?
- People with mild hand eczema often start with topical corticosteroids and skin care [2].
- People with moderate to severe graft-versus-host disease may need systemic treatment, and some may need alternatives if steroids are not effective [1].
- Children with scalp fungal infection usually need both oral and topical antifungal treatment, guided by the species involved [5].
- Women in perimenopause who notice skin or hair changes may benefit from dermatology assessment and an individualized plan [3].
Practical Implications
The most useful message from these sources is that treatment works best when it is matched to the diagnosis and the patient. Accurate identification comes first.
For hand eczema, this may include patch testing. For scalp infections, identifying the fungal species guides the choice of medicine [2,5].
Guidelines are also meant to be adapted. The German guideline summary notes that recommendations must be individualized for each patient, and that guidelines differ in how strongly their evidence has been developed [4].
Risks and Safety Concerns
Systemic treatments, including corticosteroids, targeted immune drugs and oral antifungals, can have side effects. Some need monitoring, and some are not appropriate for every person.
The sources reviewed here do not provide a full safety profile for each medicine, so readers should not rely on this article for that information.
Off-label use, such as the use of terbinafine and itraconazole in some pediatric scalp infections, requires careful clinical judgment and should be discussed with a qualified doctor [5].
Similarly, hormone therapy decisions involve benefits and uncertainties that differ from person to person [3].
Limitations of Current Research
This article is based on abstracts of five sources, not on full texts. No randomized controlled trials were included in the reviewed set.
Several sources are narrative reviews, which summarize literature without a fully systematic method. Guidelines may rely on expert opinion where trial data are scarce [1,2,3,4,5].
Several gaps stand out. Hand eczema lacks standardized diagnostic tools and evidence-based treatment algorithms [2].
Menopausal skin research notes areas where evidence is limited [3]. Stem cell-based therapies for GVHD remain investigational [1].
Finally, many sexual health and dermatology studies have underrepresented women, which may limit how well findings apply to young women [3].
Frequently Asked Questions
Is there strong evidence for treating chronic hand eczema?
Topical corticosteroids are described as first-line therapy, and patch testing is the gold standard for finding relevant allergies [2]. Newer options are being added, but the field still lacks standardized treatment algorithms [2].
Are newer treatments for graft-versus-host disease proven?
Targeted systemic agents are used in established algorithms or specific situations [1]. Cell-based therapies such as mesenchymal stromal cells and regulatory T cells are described as emerging and still investigational [1].
Why do children with scalp fungus need two types of treatment?
Topical treatment alone is generally considered insufficient, so guidelines recommend combining oral and topical antifungals [5].
Does menopause really affect the skin?
Yes. Skin barrier changes, thinning, pigment changes, hair changes and acne can occur, linked to estrogen decline and relative androgen excess [3].
Are German guidelines different from other guidelines?
German dermatology guidelines are developed by national societies under standardized methods, but they differ in methodology and evidence synthesis depending on their development level [4].
Should I change my treatment based on this article?
No. This article is educational. Treatment decisions should be made with a doctor who knows your full medical history.
Key Takeaways
- Guidelines combine research, expert opinion and clinical judgment. Not all recommendations are based on randomized trials [1,2,3,4,5].
- Chronic hand eczema is commonly treated in steps, starting with topical corticosteroids [2].
- Graft-versus-host disease of the skin may require systemic therapy, and several targeted and cell-based options are being studied [1].
- Menopausal skin and hair changes have hormonal causes, but the evidence for some treatments remains limited [3].
- Tinea capitis usually needs combined oral and topical antifungal treatment, chosen by the fungal species [5].
Medical Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Consult a qualified healthcare professional before making treatment decisions.
References
- A Review of Modern Therapies and New Innovations in the Treatment of Cutaneous Graft-versus-Host Disease.. DOI: https://doi.org/10.1007/s13555-026-01919-3
- The Patient Journey: From Diagnosis to Therapeutic Management of Chronic Hand Eczema.. DOI: https://doi.org/10.1177/17103568251408034
- Cutaneous Manifestations of the Menopausal Transition – Part 2: Hormonal Frameworks and Management of Skin and Hair Concerns.. DOI: https://doi.org/10.1016/j.jaad.2026.11.027
- [Current dermatology guidelines in Germany: selected clinically relevant recommendations].. DOI: https://doi.org/10.1007/s00105-026-05795-y
- Consensus-based Guideline on tinea capitis.. DOI: https://doi.org/10.1111/ddg.70395x
Recommended Metabolic Health & Wellness Products
A curated index of metabolic support compounds, prebiotic fibres, functional botanicals, and zero-sugar pantry staples selected for ingredient quality and scientific relevance.
Transparency Notice: As an Amazon Associate, Dibesity.com earns from qualifying purchases made through external affiliate links, at no extra cost to you.
Targeted Metabolic & Cellular Support
Apigenin Powder
A bioflavonoid compound explored for cellular protection, circadian rhythm support, and metabolic balance.
View on Amazon →97% Pure Berberine Powder (100 g)
High-purity berberine HCl powder for customizable serving sizes and metabolic pathway support.
View on Amazon →Berberine Powder (200 g)
Bulk berberine powder formulation. Check the listing for ingredient details, certificates of analysis, and reviews.
View on Amazon →Pure Inositol Powder
Pure Myo-Inositol and D-Chiro-Inositol powder formulation for metabolic and reproductive wellness. Check the listing for details.
View on Amazon →Functional Botanicals & Prebiotic Fibres
Psyllium Husk with Fennel & Cardamom
A soluble prebiotic fibre blend with warming digestive spices to support gut motility and postprandial glucose moderation.
View on Amazon →100% Pure Hibiscus Powder
Anthocyanin-rich botanical powder supporting cardiometabolic markers, nitric oxide pathways, and vascular health.
View on Amazon →Roasted Barley Powder
A roasted whole-grain grain alternative suitable for nutritious, caffeine-free herbal teas and warm beverages.
View on Amazon →Allulose Confectionery (Low-Glycaemic)
Strawberry Allulose Gummies
Low-calorie, rare-sugar allulose gummies designed to satisfy sweet cravings without causing glycemic spikes.
View on Amazon →Watermelon Allulose Gummies
Refreshing watermelon flavour sweetened with keto-compatible allulose. Minimal net impact on blood sugar.
View on Amazon →Mixed Berry Allulose Gummies
Berry-flavoured chewable treats sweetened with rare sugar allulose for a clean, tooth-friendly profile.
View on Amazon →
